|
[1]
|
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
|
|
[2]
|
Lyu, B., Hwang, Y.J., Selvin, E., Jameson, B.C., Chang, A.R., Grams, M.E., et al. (2022) Glucose-Lowering Agents and the Risk of Hypoglycemia: A Real-World Study. Journal of General Internal Medicine, 38, 107-114. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Liu, L., Liu, J., Xu, L., Ke, W., Wan, X., Li, H., et al. (2017) Lower Mean Blood Glucose during Short‐Term Intensive Insulin Therapy Is Associated with Long‐Term Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes: Evidence‐Based Recommendations for Standardization. Journal of Diabetes Investigation, 9, 908-916. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Sun, R., Banerjee, I., Sang, S., Joseph, J., Schneider, J. and Hernandez-Boussard, T. (2021) Type 1 Diabetes Management with Technology: Patterns of Utilization and Effects on Glucose Control Using Real-World Evidence. Clinical Diabetes, 39, 284-292. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Grunberger, G., Handelsman, Y., Bloomgarden, Z., Fonseca, V.A., Garber, A.J., Haas, R.A., et al. (2018) American Association of Clinical Endocrinologists and American College of Endocrinology 2018 Position Statement on Integration of Insulin Pumps and Continuous Glucose Monitoring in Patients with Diabetes Mellitus. Endocrine Practice, 24, 302-308. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Williams, D.M., Jones, H. and Stephens, J.W. (2022) Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 15, 281-295. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Beck, R.W., Bergenstal, R.M., Riddlesworth, T.D., Kollman, C., Li, Z., Brown, A.S., et al. (2018) Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes Care, 42, 400-405. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Zheng, Y., Ley, S.H. and Hu, F.B. (2017) Global Aetiology and Epidemiology of Type 2 Diabetes Mellitus and Its Complications. Nature Reviews Endocrinology, 14, 88-98. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Yuksel, M. and Bektas, H. (2021) Compliance with Treatment and Fear of Hypoglycaemia in Patients with Type 2 Diabetes. Journal of Clinical Nursing, 30, 1773-1786. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Studer, C.M., Linder, M. and Pazzagli, L. (2023) A Global Systematic Overview of Socioeconomic Factors Associated with Antidiabetic Medication Adherence in Individuals with Type 2 Diabetes. Journal of Health, Population and Nutrition, 42, Article No. 122. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Choudhary, P., Campbell, F., Joule, N. and Kar, P. (2019) A Type 1 Diabetes Technology Pathway: Consensus Statement for the Use of Technology in Type 1 Diabetes. Diabetic Medicine, 36, 531-538. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Natale, P., Chen, S., Chow, C.K., Cheung, N.W., Martinez‐Martin, D., Caillaud, C., et al. (2023) Patient Experiences of Continuous Glucose Monitoring and Sensor‐Augmented Insulin Pump Therapy for Diabetes: A Systematic Review of Qualitative Studies. Journal of Diabetes, 15, 1048-1069. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Umpierrez, G.E. and Klonoff, D.C. (2018) Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care, 41, 1579-1589. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Handelsman, Y., Anderson, J.E., Bakris, G.L., Ballantyne, C.M., Bhatt, D.L., Bloomgarden, Z.T., et al. (2024) DCRM 2.0: Multispecialty Practice Recommendations for the Management of Diabetes, Cardiorenal, and Metabolic Diseases. Metabolism, 159, Article 155931. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Zhao, Q., Li, H., Ni, Q., Dai, Y., Zheng, Q., Wang, Y., et al. (2022) Follow‐up Frequency and Clinical Outcomes in Patients with Type 2 Diabetes: A Prospective Analysis Based on Multicenter Real‐World Data. Journal of Diabetes, 14, 306-314. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B.B., et al. (2022) IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Research and Clinical Practice, 183, Article 109119. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Bao, Y. and Zhu, D. (2022) Clinical Application Guidelines for Blood Glucose Monitoring in China (2022 Edition). Diabetes/Metabolism Research and Reviews, 38, e3581. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
中华医学会内分泌学分会, 中华医学会糖尿病学分会, 中国医师协会内分泌代谢科医师分会. 中国胰岛素泵治疗指南(2021年版) [J]. 中华内分泌代谢杂志, 2021, 37(8): 679-701.
|
|
[19]
|
Dermawan, D. and Kenichi Purbayanto, M.A. (2022) An Overview of Advancements in Closed-Loop Artificial Pancreas System. Heliyon, 8, e11648. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Galindo, R.J. and Aleppo, G. (2020) Continuous Glucose Monitoring: The Achievement of 100 Years of Innovation in Diabetes Technology. Diabetes Research and Clinical Practice, 170, Article 108502. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Ben-Yacov, O., Godneva, A., Rein, M., Shilo, S., Kolobkov, D., Koren, N., et al. (2021) Personalized Postprandial Glucose Response-Targeting Diet versus Mediterranean Diet for Glycemic Control in Prediabetes. Diabetes Care, 44, 1980-1991. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Stone, J.Y. and Bailey, T.S. (2020) Benefits and Limitations of Continuous Glucose Monitoring in Type 1 Diabetes. Expert Review of Endocrinology & Metabolism, 15, 41-49. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Chlup, R., Runzis, S., Castaneda, J., Lee, S.W., Nguyen, X. and Cohen, O. (2018) Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c Reduction. Diabetes Technology & Therapeutics, 20, 153-159. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Kovatchev, B. (2019) Glycemic Variability: Risk Factors, Assessment, and Control. Journal of Diabetes Science and Technology, 13, 627-635. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Boughton, C.K., Daly, A., Thabit, H., Hartnell, S., Herzig, D., Vogt, A., et al. (2021) Day‐to‐Day Variability of Insulin Requirements in the Inpatient Setting: Observations during Fully Closed‐Loop Insulin Delivery. Diabetes, Obesity and Metabolism, 23, 1978-1982. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Battelino, T., Danne, T., Bergenstal, R.M., Amiel, S.A., Beck, R., Biester, T., et al. (2019) Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care, 42, 1593-1603. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Yapanis, M., James, S., Craig, M.E., O’Neal, D. and Ekinci, E.I. (2022) Complications of Diabetes and Metrics of Glycemic Management Derived from Continuous Glucose Monitoring. The Journal of Clinical Endocrinology & Metabolism, 107, e2221-e2236. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Polonsky, W.H., Hessler, D., Ruedy, K.J. and Beck, R.W. (2017) The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults with Type 1 Diabetes: Further Findings from the DIAMOND Randomized Clinical Trial. Diabetes Care, 40, 736-741. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Charleer, S., Mathieu, C., Nobels, F., De Block, C., Radermecker, R.P., Hermans, M.P., et al. (2018) Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study. The Journal of Clinical Endocrinology & Metabolism, 103, 1224-1232. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Tanenbaum, M.L., Hanes, S.J., Miller, K.M., Naranjo, D., Bensen, R. and Hood, K.K. (2016) Diabetes Device Use in Adults with Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets. Diabetes Care, 40, 181-187. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Messer, L.H., Johnson, R., Driscoll, K.A. and Jones, J. (2017) Best Friend or Spy: A Qualitative Meta‐Synthesis on the Impact of Continuous Glucose Monitoring on Life with Type 1 Diabetes. Diabetic Medicine, 35, 409-418. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
van Beers, C.A.J., DeVries, J.H., Kleijer, S.J., Smits, M.M., Geelhoed-Duijvestijn, P.H., Kramer, M.H.H., et al. (2016) Continuous Glucose Monitoring for Patients with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia (IN CONTROL): A Randomised, Open-Label, Crossover Trial. The Lancet Diabetes & Endocrinology, 4, 893-902. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Pratley, R.E., Kanapka, L.G., Rickels, M.R., Ahmann, A., Aleppo, G., Beck, R., et al. (2020) Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 Diabetes: A Randomized Clinical Trial. JAMA, 323, 2397-2406. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Bally, L., Gubler, P., Thabit, H., Hartnell, S., Ruan, Y., Wilinska, M.E., et al. (2019) Fully Closed-Loop Insulin Delivery Improves Glucose Control of Inpatients with Type 2 Diabetes Receiving Hemodialysis. Kidney International, 96, 593-596. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Bally, L., Thabit, H., Hartnell, S., Andereggen, E., Ruan, Y., Wilinska, M.E., et al. (2018) Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care. New England Journal of Medicine, 379, 547-556. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Murphy, H.R. (2020) Managing Diabetes in Pregnancy Before, During, and after COVID-19. Diabetes Technology & Therapeutics, 22, 454-461. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Kovatchev, B. and Cobelli, C. (2016) Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes. Diabetes Care, 39, 502-510. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Moreno-Fernandez, J., Gómez, F.J., Gálvez Moreno, M.Á. and Castaño, J.P. (2016) Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial. Journal of Diabetes Research, 2016, Article 4171789. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Nemlekar, P., Hannah, K. and Norman, G.J. (2023) 358-OR: Better Adherence to Real-Time Continuous Glucose Monitoring (rtCGM) than to Intermittently Scanned CGM (isCGM) among People with Type 2 Diabetes (PWT2D) on Intensive Insulin Therapy (IIT). Diabetes, 72, 358-OR. [Google Scholar] [CrossRef]
|
|
[40]
|
Eysenbach, G. (2011) CONSORT-EHEALTH: Improving and Standardizing Evaluation Reports of Web-Based and Mobile Health Interventions. Journal of Medical Internet Research, 13, e126. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Hopkins, D., Lawrence, I., Mansell, P., Thompson, G., Amiel, S., Campbell, M., et al. (2012) Improved Biomedical and Psychological Outcomes 1 Year after Structured Education in Flexible Insulin Therapy for People with Type 1 Diabetes: The U.K. DAFNE Experience. Diabetes Care, 35, 1638-1642. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Messer, L., Ruedy, K., Xing, D., Coffey, J., Englert, K., Caswell, K., et al. (2009) Educating Families on Real Time Continuous Glucose Monitoring. The Diabetes Educator, 35, 124-135. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Marigliano, M., Morandi, A., Maschio, M., Sabbion, A., Contreas, G., Tomasselli, F., et al. (2013) Nutritional Education and Carbohydrate Counting in Children with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion: The Effects on Dietary Habits, Body Composition and Glycometabolic Control. Acta Diabetologica, 50, 959-964. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Mamtani, R., Wolinsky, T. and Simon, B. (2022) 912-P: Integrating CGM Use into Primary Care Practice: A Diabetes Quality Improvement Project. Diabetes, 71, 912-P. [Google Scholar] [CrossRef]
|
|
[45]
|
Schiavon, M., Dalla Man, C. and Cobelli, C. (2018) Insulin Sensitivity Index-Based Optimization of Insulin to Carbohydrate Ratio: In Silico Study Shows Efficacious Protection against Hypoglycemic Events Caused by Suboptimal Therapy. Diabetes Technology & Therapeutics, 20, 98-105. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Zeng, A., Beltran, A., Bell, T. and Wood, R. (2024) 1053-P: Enhancing Accessibility—Assessing the Impact of Expanded CGM Coverage on CGM Adoption. Diabetes, 73, 1053-P. [Google Scholar] [CrossRef]
|
|
[47]
|
Murata, T., Kuroda, A., Matsuhisa, M., Toyoda, M., Kimura, M., Hirota, Y., et al. (2020) Predictive Factors of the Adherence to Real-Time Continuous Glucose Monitoring Sensors: A Prospective Observational Study (PARCS Study). Journal of Diabetes Science and Technology, 15, 1084-1092. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
de Bock, M., Cooper, M., Retterath, A., Nicholas, J., Ly, T., Jones, T., et al. (2016) Continuous Glucose Monitoring Adherence: Lessons from a Clinical Trial to Predict Outpatient Behavior. Journal of Diabetes Science and Technology, 10, 627-632. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Riemsma, R., Corro Ramos, I., Birnie, R., Büyükkaramikli, N., Armstrong, N., Ryder, S., et al. (2016) Integrated Sensor-Augmented Pump Therapy Systems [The Minimed® Paradigm™ Veo System and the Vibe™ and G4® PLATINUM CGM (Continuous Glucose Monitoring) System] for Managing Blood Glucose Levels in Type 1 Diabetes: A Systematic Review and Economic Evaluation. Health Technology Assessment, 20, 1-252. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Alshannaq, H., Norman, G.J. and Lynch, P.M. (2024) 1035-P: Cost-Effectiveness of Real-Time CGM Vs. Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes from a U.S. Payor Perspective. Diabetes, 73, 1035-P. [Google Scholar] [CrossRef]
|
|
[51]
|
Alshannaq, H., Ahmed, M., Norman, G.J. and Simmons, D. (2024) 1036-P: Cost-Effectiveness of Real-Time CGM Vs. Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Intensive Insulin Therapy in Australia. Diabetes, 73, 1036-P. [Google Scholar] [CrossRef]
|
|
[52]
|
Harris, S.B., Cimino, S., Thanh YEN Nguyen, T., Poon, Y. and Szafranski, K. (2024) 1051-P: Cost-Effectiveness of Flash CGM Compared with SMBG—A Canadian Private-Payer Perspective. Diabetes, 73, 1051-P. [Google Scholar] [CrossRef]
|
|
[53]
|
Catherine, J.P., Russell, M.V. and Peter, C.H. (2021) The Impact of Race and Socioeconomic Factors on Paediatric Diabetes. eClinicalMedicine, 42, Article 101186. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Dexcom G7 Continuous Glucose Monitoring System User Guide.
https://www.dexcom.com/g7-cgm-system
|
|
[55]
|
Kovatchev, B. (2018) Automated Closed-Loop Control of Diabetes: The Artificial Pancreas. Bioelectronic Medicine, 4, Article No. 14. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Hanazaki, K., Tanioka, N., Munekage, M., Uemura, S. and Maeda, H. (2021) Closed‐Loop Artificial Endocrine Pancreas from Japan. Artificial Organs, 45, 958-967. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Vigersky, R.A. and McMahon, C. (2019) The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes. Diabetes Technology & Therapeutics, 21, 81-85. [Google Scholar] [CrossRef] [PubMed]
|